Exane Derivatives’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2
Closed -$354 762
2020
Q1
$354 Hold
2
﹤0.01% 628
2019
Q4
$388 Hold
2
﹤0.01% 631
2019
Q3
$337 Sell
2
-26,438
-100% -$4.31M ﹤0.01% 610
2019
Q2
$4.43M Buy
26,440
+25,679
+3,374% +$3.56M 0.86% 23
2019
Q1
$111K Sell
761
-1,552
-67% -$225K 0.03% 285
2018
Q4
$309K Buy
2,313
+1,821
+370% +$299K 0.07% 210
2018
Q3
$93.9K Sell
492
-15,882
-97% -$2.92M 0.02% 326
2018
Q2
$2.73M Buy
+16,374
New +$2.63M 0.58% 39
2018
Q1
Sell
-7,547
Closed -$1.24M 679
2017
Q4
$1.24M Buy
7,547
+5,883
+354% +$1.06M 0.26% 87
2017
Q3
$341K Buy
1,664
+915
+122% +$213K 0.09% 158
2017
Q2
$182K Sell
749
-1,361
-65% -$320K 0.05% 207
2017
Q1
$504K Buy
2,110
+1,384
+191% +$322K 0.13% 130
2016
Q4
$152K Buy
726
+725
+72,500% +$150K 0.04% 213
2016
Q3
$230 Buy
+1
New +$244 ﹤0.01% 509
2015
Q2
Sell
-74,025
Closed -$22M 580
2015
Q1
$22M Buy
74,025
+73,863
+45,594% +$21.1M 2.68% 11
2014
Q4
$41.7K Buy
+162
New +$40.5K 0.01% 341

Other funds holding AGN